22.418 articles found

Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and Entacapone

DEVANE JOHN G, STARK PAUL, FANNING NIALL M. M, REKHI GURVINDER SINGH, LIVERSIDGE GARY, JENKINS SCOTT A.

· 2006-06-05

Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein.

Waza M, Adachi H, Katsuno M, Minamiyama M, Tanaka F, Doyu M, Sobue G.

J Mol Med (Berl) · 2006-06-02

DOI: 10.1007/s00109-006-0066-0PMID: 16741751

Patterns of initial pharmacotherapy for Parkinson's disease in the United States.

Huse DM, Castelli-Haley J, Orsini LS, Lenhart G, Abdalla JA.

J Geriatr Psychiatry Neurol · 2006-06-01

DOI: 10.1177/0891988706286512PMID: 16690994

Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study.

Brandt-Christensen M, Kvist K, Nilsson FM, Andersen PK, Kessing LV.

J Neurol Neurosurg Psychiatry · 2006-06-01

DOI: 10.1136/jnnp.2005.083345PMID: 16705201

Pharmacotherapy for neurogenic detrusor overactivity.

Chancellor MB, Anderson RU, Boone TB.

Am J Phys Med Rehabil · 2006-06-01

DOI: 10.1097/01.phm.0000219229.92056.c2PMID: 16715024

Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.

Zanetti R, Loria D, Rosso S.

Melanoma Res · 2006-06-01

DOI: 10.1097/01.cmr.0000215043.61306.d7PMID: 16718266

Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in Parkinson's disease.

Obering CD, Chen JJ, Swope DM.

Pharmacotherapy · 2006-06-01

DOI: 10.1592/phco.26.6.840PMID: 16716137

Secondary parkinsonism in childhood: A rare complication after radiotherapy.

Voermans NC, Bloem BR, Janssens G, Vogel WV, Sie LT.

Pediatr Neurol · 2006-06-01

DOI: 10.1016/j.pediatrneurol.2005.10.021PMID: 16765832

Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study.

Jiang YM, Mo XA, Du FQ, Fu X, Zhu XY, Gao HY, Xie JL, Liao FL, Pira E, Zheng W.

J Occup Environ Med · 2006-06-01

DOI: 10.1097/01.jom.0000204114.01893.3ePMID: 16766929

Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD.

Fregni F, Ono CR, Santos CM, Bermpohl F, Buchpiguel C, Barbosa ER, Marcolin MA, Pascual-Leone A, Valente KD.

Neurology · 2006-06-01

DOI: 10.1212/01.wnl.0000218194.12054.60PMID: 16769932

[Transdermal rotigotine as monotherapy for Parkinson disease].

Wasielewski S.

Med Monatsschr Pharm · 2006-06-01

PMID: 16792208

Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study.

Postuma RB, Espay AJ, Zadikoff C, Suchowersky O, Martin WR, Lafontaine AL, Ranawaya R, Camicioli R, Lang AE.

Neurology · 2006-06-01

DOI: 10.1212/01.wnl.0000219815.83681.f7PMID: 16801668